Literature DB >> 18316518

The Lys234Arg substitution in the enzyme SHV-72 is a determinant for resistance to clavulanic acid inhibition.

Nuno Mendonça1, Vera Manageiro, Frédéric Robin, M José Salgado, Eugénia Ferreira, Manuela Caniça, Richard Bonnet.   

Abstract

The new beta-lactamase SHV-72 was isolated from clinical Klebsiella pneumoniae INSRA1229, which exhibited the unusual association of resistance to the amoxicillin-clavulanic acid combination (MIC, 64 microg/ml) and susceptibility to cephalosporins, aztreonam, and imipenem. SHV-72 (pI 7.6) harbored the three amino acid substitutions Ile8Phe, Ala146Val, and Lys234Arg. SHV-72 had high catalytic efficiency against penicillins (k(cat)/K(m), 35 to 287 microM(-1) x s(-1)) and no activity against oxyimino beta-lactams. The concentration of clavulanic acid necessary to inhibit the enzyme activity by 50% was 10-fold higher for SHV-72 than for SHV-1. Molecular-dynamics simulation suggested that the Lys234Arg substitution in SHV-72 stabilized an atypical conformation of the Ser130 side chain, which moved the O gamma atom of Ser130 around 3.5 A away from the key O gamma atom of the reactive serine (Ser70). This movement may therefore decrease the susceptibility to clavulanic acid by preventing cross-linking between Ser130 and Ser70.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18316518      PMCID: PMC2346665          DOI: 10.1128/AAC.01381-07

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  32 in total

1.  Diversity of SHV and TEM beta-lactamases in Klebsiella pneumoniae: gene evolution in Northern Taiwan and two novel beta-lactamases, SHV-25 and SHV-26.

Authors:  F Y Chang; L K Siu; C P Fung; M H Huang; M Ho
Journal:  Antimicrob Agents Chemother       Date:  2001-09       Impact factor: 5.191

2.  High-resolution X-ray structure of an acyl-enzyme species for the class D OXA-10 beta-lactamase.

Authors:  Laurent Maveyraud; Dasantila Golemi-Kotra; Akihiro Ishiwata; Oussama Meroueh; Shahriar Mobashery; Jean-Pierre Samama
Journal:  J Am Chem Soc       Date:  2002-03-20       Impact factor: 15.419

Review 3.  Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat.

Authors:  P A Bradford
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

4.  The structural bases of antibiotic resistance in the clinically derived mutant beta-lactamases TEM-30, TEM-32, and TEM-34.

Authors:  Xiaojun Wang; George Minasov; Brian K Shoichet
Journal:  J Biol Chem       Date:  2002-06-10       Impact factor: 5.157

5.  Emergence in Klebsiella pneumoniae of a chromosome-encoded SHV beta-lactamase that compromises the efficacy of imipenem.

Authors:  Laurent Poirel; Claire Héritier; Isabelle Podglajen; Wladimir Sougakoff; Laurent Gutmann; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

6.  Epidemiological survey of amoxicillin-clavulanate resistance and corresponding molecular mechanisms in Escherichia coli isolates in France: new genetic features of bla(TEM) genes.

Authors:  V Leflon-Guibout; V Speldooren; B Heym; M Nicolas-Chanoine
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

7.  Occurrence of a novel SHV-type enzyme (SHV-55) among isolates of Klebsiella pneumoniae from Portuguese origin in a comparison study for extended-spectrum beta-lactamase-producing evaluation.

Authors:  Nuno Mendonça; Eugénia Ferreira; Manuela Caniça
Journal:  Diagn Microbiol Infect Dis       Date:  2006-08-28       Impact factor: 2.803

8.  An ultrahigh resolution structure of TEM-1 beta-lactamase suggests a role for Glu166 as the general base in acylation.

Authors:  George Minasov; Xiaojun Wang; Brian K Shoichet
Journal:  J Am Chem Soc       Date:  2002-05-15       Impact factor: 15.419

9.  Novel cefotaximase (CTX-M-16) with increased catalytic efficiency due to substitution Asp-240-->Gly.

Authors:  R Bonnet; C Dutour; J L Sampaio; C Chanal; D Sirot; R Labia; C De Champs; J Sirot
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

10.  Insights into the molecular basis for the carbenicillinase activity of PSE-4 beta-lactamase from crystallographic and kinetic studies.

Authors:  D Lim; F Sanschagrin; L Passmore; L De Castro; R C Levesque; N C Strynadka
Journal:  Biochemistry       Date:  2001-01-16       Impact factor: 3.162

View more
  16 in total

1.  Biochemical characterization of SHV-55, an extended-spectrum class A beta-lactamase from Klebsiella pneumoniae.

Authors:  Nuno Mendonça; Vera Manageiro; Richard Bonnet; Manuela Caniça
Journal:  Antimicrob Agents Chemother       Date:  2008-03-03       Impact factor: 5.191

2.  Biochemical study of a new inhibitor-resistant beta-lactamase, SHV-84, produced by a clinical Escherichia coli strain.

Authors:  Vera Manageiro; Eugénia Ferreira; Luís Albuquerque; Richard Bonnet; Manuela Caniça
Journal:  Antimicrob Agents Chemother       Date:  2010-03-08       Impact factor: 5.191

3.  Role of SHV β-lactamase variants in resistance of clinical Klebsiella pneumoniae strains to β-lactams in an Algerian hospital.

Authors:  Nadjia Ramdani-Bouguessa; Vera Manageiro; Daniela Jones-Dias; Eugénia Ferreira; Mohamed Tazir; Manuela Caniça
Journal:  J Med Microbiol       Date:  2011-03-17       Impact factor: 2.472

4.  In vitro selection of variants resistant to beta-lactams plus beta-lactamase inhibitors in CTX-M beta-lactamases: predicting the in vivo scenario?

Authors:  Aida Ripoll; Fernando Baquero; Angela Novais; Mario J Rodríguez-Domínguez; Maria-Carmen Turrientes; Rafael Cantón; Juan-Carlos Galán
Journal:  Antimicrob Agents Chemother       Date:  2011-07-25       Impact factor: 5.191

5.  Detection of resistance to beta-lactamase inhibitors in strains with CTX-M beta-lactamases: a multicenter external proficiency study using a well-defined collection of Escherichia coli strains.

Authors:  Aida Ripoll; Juan-Carlos Galán; Cristina Rodríguez; Nuria Tormo; Concepción Gimeno; Fernando Baquero; Luis Martínez-Martínez; Rafael Cantón
Journal:  J Clin Microbiol       Date:  2013-10-23       Impact factor: 5.948

6.  Characterization of the inhibitor-resistant SHV β-lactamase SHV-107 in a clinical Klebsiella pneumoniae strain coproducing GES-7 enzyme.

Authors:  Vera Manageiro; Eugénia Ferreira; Antony Cougnoux; Luís Albuquerque; Manuela Caniça; Richard Bonnet
Journal:  Antimicrob Agents Chemother       Date:  2011-11-14       Impact factor: 5.191

7.  Combinatorial active-site variants confer sustained clavulanate resistance in BlaC β-lactamase from Mycobacterium tuberculosis.

Authors:  Philippe Egesborg; Hélène Carlettini; Jordan P Volpato; Nicolas Doucet
Journal:  Protein Sci       Date:  2014-12-30       Impact factor: 6.725

8.  Design and exploration of novel boronic acid inhibitors reveals important interactions with a clavulanic acid-resistant sulfhydryl-variable (SHV) β-lactamase.

Authors:  Marisa L Winkler; Elizabeth A Rodkey; Magdalena A Taracila; Sarah M Drawz; Christopher R Bethel; Krisztina M Papp-Wallace; Kerri M Smith; Yan Xu; Jeffrey R Dwulit-Smith; Chiara Romagnoli; Emilia Caselli; Fabio Prati; Focco van den Akker; Robert A Bonomo
Journal:  J Med Chem       Date:  2013-02-04       Impact factor: 7.446

9.  Substitutions at position 105 in SHV family β-lactamases decrease catalytic efficiency and cause inhibitor resistance.

Authors:  Mei Li; Benjamin C Conklin; Magdalena A Taracila; Rebecca A Hutton; Marion J Skalweit
Journal:  Antimicrob Agents Chemother       Date:  2012-08-20       Impact factor: 5.191

10.  The evolutionary histories of clinical and environmental SHV β-lactamases are intertwined.

Authors:  Robert L Dorit; Christopher M Roy; Sandra M Robinson; Margaret A Riley
Journal:  J Mol Evol       Date:  2013-07-17       Impact factor: 2.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.